Qatar Pharmaceuticals and Healthcare Report Q1 2013

  • ID: 2373652
  • January 2013
  • Region: Qatar
  • 83 pages
  • Business Monitor International


  • Company Profiles
  • Ebn Sina Medical
  • GlaxoSmithKline
  • Local Companies
  • Medicare Group
  • Merck & Co
  • MORE

BMI View

According to recent reports in The Gulf Times, Qatar will have four new drug manufacturers by the end of Q113. The drugmakers will reportedly import their raw materials and produce tablets,
syrups and injectables. It is anticipated the drug manufacturers will (in our view eventually) help curb reliance on imports and lower prices of retail medicines in the country as a result of increased local competition, according to Dr Aisha al-Ansari of the Supreme Council of Health Pharmacy and Drug Control Department (SCH). If the production facilities are opened on schedule, we will revise our forecasts accordingly. Generally speaking, however, we expect Qatar to remain greatly reliant on imported medicines, given the high level of consumption of patented drugs.

Headline Expenditure Projections

- Pharmaceuticals: QAR1.32bn (US$362mn) in 2011 to QAR1.38bn (US$379mn) in 2012;
+4.7% in local currency and US dollar terms. Historical figures adjusted to reflect new import data.

- Healthcare: QAR10.54bn (US$2.89bn) in 2011 to QAR11.40bn (US$3.13bn) in 2012; +8.2
%in local currency and US dollar terms. Forecast slightly lower from Q412 on account of macroeconomic READ MORE >

Note: Product cover images may vary from those shown


  • Company Profiles
  • Ebn Sina Medical
  • GlaxoSmithKline
  • Local Companies
  • Medicare Group
  • Merck & Co
  • MORE

Executive Summary 5

SWOT Analysis 7

Qatar Pharmaceuticals And Healthcare Industry SWOT 7

Qatar Political SWOT 8

Qatar Economic SWOT 8

Qatar Business Environment SWOT 9

Pharmaceutical Risk/Reward Ratings 10
Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113 11

Rewards 12

Risks 12

Qatar - Market Summary 14

Regulatory Regime 15

Regional Regulatory Developments 16

FTA Agreements 17

Intellectual Property Regime 18

Pricing And Reimbursement Regime 19

Drug Price Reform Failure 19

Industry Developments 21

Epidemiology 21

Non-Communicable Diseases 22

Communicable Diseases 25

Healthcare Sector 25

Regional Healthcare Sector Developments 27

Healthcare Reform 28

Health Insurance 29

Healthcare IT 30

Research & Development 31

Clinical Trials 33

Medical Devices Industry 33

Recent Developments in the Medical Devices Industry 34

Industry Forecast Scenario 36

Pharmaceutical Market Forecast 36
Table: Pharmaceutical Sales Indicators 2008-2016 38

Healthcare Market Forecast 39
Table: Healthcare Expenditure Indicators 2008-2016 40
Table: Government Healthcare Indicators 2008-2016 40
Table: Private Healthcare Indicators 2008-2016 41

Key Growth Factors - Macroeconomic 42

Prescription Drug Market Forecast 47
Table: Prescription Drug Sales Indicators 2008-2016 48

Patented Drug Market Forecast 49
Table: Patented Drug Market Indicators 2008-2016 50

Generic Drug Market Forecast 51
Table: Generic Drug Sales Indicators 2008-2016 52

OTC Medicine Market Forecast 53
Table: OTC Medicine Sales Indicators 2008-2016 54

Pharmaceutical Trade Forecast 55
Table: Exports and Imports Indicators, 2008-2016 56

Medical Device Market Forecast 57
Table: Medical Devices Sales Indicators 2008-2016 58

Other Healthcare Data 59
Table: Healthcare Professionals (2009) 60

Key Risks To BMI's Forecasts 61

Competitive Landscape 62

Pharmaceutical Industry 62

Pharmacy Wholesale And Retail 63

Company Profiles 64

Local Companies 64

Qatari German Company For Medical Devices (QGMD) 64

Medicare Group 66

Ebn Sina Medical 67

Qatar Pharma 68

Multinational Companies 69

Novartis 69

Merck & Co 70

GlaxoSmithKline 71

Pfizer 72

Demographic Outlook 73
Table: Population By Age Group, 1990-2020 ('000) 74
Table: Population By Age Group, 1990-2020 (% of total) 74
Table: Key Population Ratios, 1990-2020 75
Table: Rural And Urban Population, 1990-2020 76

Glossary 77

BMI Methodology 79

How We Generate Our Pharmaceutical Industry Forecasts 79

Pharmaceutical Risk/Reward Ratings Methodology 80

Ratings Overview 80
Table: Pharmaceutical Risk/Reward Indicators 81

Weighting 82
Table: Weighting Of Components 82

Sources 82

Note: Product cover images may vary from those shown

Company Profiles
Local Companies
Qatari German Company For Medical Devices (QGMD)
Medicare Group
Ebn Sina Medical
Qatar Pharma
Multinational Companies
Merck & Co

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Corporation
  • Merck & Co., Inc.